Threat of 'hard Brexit' pulls down Wall Street

Go back to Threat of 'hard Brexit' pulls down Wall Street

Brean Capital Raises Price Target on Micron Technology (MU) Following 4Q Beat

October 5, 2016 10:06 AM EDT

Brean Capital reiterated a Buy rating on Micron Technology (NASDAQ: MU), and raised the price target to $23.00 (from $18.00), following the company's 4Q earnings report. MU reported revenue and non-GAAP EPS of $3.217B and $(0.05), compared to the Street's estimates at $3.150B/ $(0.12).

Analyst Mike Burton commented, "Similar to the May-16 quarter, expectations were above average... More

Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)

October 4, 2016 9:31 AM EDT

Oppenheimer affirms Summit Therapeutics (Nasdaq: SMMT) at Outperform with a price target of $28 following a new deal with Sarepta (Nasdaq: SRPT).

The firm said, Summit and Sarepta announced this morning a license and collaboration agreement... More

Baird Remains Positive on Sarepta (SRPT) Amid New DMD Deal; Affirms at 'Outperform'

October 4, 2016 9:13 AM EDT

Baird affirms Sarepta Therapeutics (Nasdaq: SRPT) at Outperform with a price target of $102 following a new licensing agreement with Summit Therapeutics (Nasdaq: SMMT).

Analyst Brian Skorney noted that there was no change to the firm's outlook on Sarepta... More